NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









GlucoModicum

GlucoModicum

Private
HelsinkiHealthcare & Life Scienceshttps://glucomodicum.com/

Last Round

VC Round

Jun 17, 2024

Total Funding Raised

$7.3M

Company Overview

GlucoModicum is a medical devices company that develops needle-free, continuous glucose monitoring technology using proprietary magnetohydrodynamic (MHD) fluid sampling.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Sensors

Business Model

B2C

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

non-invasive glucose monitoringneedle-free glucose monitorcontinuous glucose monitorCGMmagnetohydrodynamic technologyMHDdiabetes managementmedical devicewearable health monitorblood glucose testingdigital healthhealth IoTsmart glucose sensor

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GlucoModicum Comps

Public and private peers based on sector, stage, and business model.

GlucoModicum comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

GlucoModicum Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 17, 2024
VC RoundMar 1, 2022
GrantFeb 1, 2022
VC RoundOct 15, 2021
GrantJun 16, 2021
Grant
Jan 15, 2020

Key People

Founding team and executive leadership

Alejandro García Pérez

Chief Technology Officer Co-Founder

Founding Team

GlucoModicum Investors

Notable investors and investment history

GlucoModicum investors
InvestorRounds
European Innovation Council FundGrant, VC Round
Business FinlandGrant, Seed
University of HelsinkiPre Seed
Åbo Akademi UniversityPre Seed, Seed
EIC FundVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 16, 2021

    $3M raised from the European Innovation Council.

  • Jan 15, 2020

    Received funding from Business Finland.

GlucoModicum Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

GlucoModicum Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about GlucoModicum's valuation, stock price, and market status.

Firmographic Details

HeadquartersHelsinki
Employee Range55
Year Founded2018
Last FundingJun 17, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.